Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
+9.04M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$97.7M
-
Put/Call ratio
-
0.08
-
Number of buys
-
64
-
Number of sells
-
-30
-
Price
-
$10.74
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2015
115 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2015.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
of 363M outstanding shares and own 29.14% of the company stock.
Largest 10 shareholders include Artal Group S.A. (57.5M shares), FMR LLC (15.5M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (8.39M shares), Ulys, L.L.C. (4.32M shares), VANGUARD GROUP INC (2.91M shares), STATE STREET CORP (2.48M shares), BlackRock Fund Advisors (2.44M shares), BRIDGER MANAGEMENT, LLC (1.29M shares), BlackRock Institutional Trust Company, N.A. (1.08M shares), and Voya Investment Management LLC (963K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.